IL-33 in T Cell Differentiation, Function, and Immune Homeostasis

Trends in Immunology

Volumn 37, Issue 5, 2016, Pages 321-333

  Peine, Michael ^a,b   Marek, Roman M ^a,b,c   Löhning, Max ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Alarmin IL 33; CD4+ and CD8+ T cell subsets; ST2 T1 IL 1RL1; STAT4 STAT5; T bet GATA 3 Foxp3; Th1 Th2 Treg CTL

Indexed keywords

INTERLEUKIN 33; TRANSCRIPTION FACTOR GATA 3; GATA3 PROTEIN, HUMAN; IL1RL1 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN;

CELL DIFFERENTIATION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGICAL FEEDBACK;

ANIMALS; CELL DIFFERENTIATION; FEEDBACK, PHYSIOLOGICAL; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84962033988     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.03.007     Document Type: Review

References (120)

1. Schmitz J., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
2. Moussion C., et al. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?. PLoS ONE 2008, 3:e3331.
3. Carriere V., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:282-287.
4. Pichery M., et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 2012, 188:3488-3495.
5. Cayrol C., Girard J.P. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 2014, 31C:31-37.
6. Kouzaki H., et al. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J. Immunol. 2011, 186:4375-4387.
7. Kakkar R., et al. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J. Biol. Chem. 2012, 287:6941-6948.
8. Zhao W.H., Hu Z.Q. Up-regulation of IL-33 expression in various types of murine cells by IL-3 and IL-4. Cytokine 2012, 58:267-273.
9. Meephansan J., et al. Regulation of IL-33 expression by IFN-γ and tumor necrosis factor-α in normal human epidermal keratinocytes. J. Invest. Dermatol. 2012, 132:2593-2600.
10. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 1989, 258:301-304.
11. Klemenz R., et al. Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:5708-5712.
12. Löhning M., et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6930-6935.
13. Xu D., et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 1998, 187:787-794.
14. + T cells from schistosome egg-induced granulomas: analysis of Th cell cytokine coexpression ex vivo. J. Immunol. 1999, 162:3882-3889.
15. Coyle A.J., et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 1999, 190:895-902.
16. Moritz D.R., et al. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 1998, 161:4866-4874.
17. Gachter T., et al. GATA-dependent expression of the interleukin-1 receptor-related T1 gene in mast cells. Mol. Cell. Biol. 1998, 18:5320-5331.
18. Gachter T., et al. Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J. Biol. Chem. 1996, 271:124-129.
19. Moritz D.R., et al. Expression analysis of the soluble and membrane-associated forms of the interleukin-1 receptor-related T1 protein in primary mast cells and fibroblasts. Hybridoma 1998, 17:107-116.
20. Monticelli L.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 2011, 12:1045-1054.
21. Mjosberg J.M., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 2011, 12:1055-1062.
22. Neill D.R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
23. + lymphoid cells. Nature 2010, 463:540-544.
24. H2 cytokine responses. Nature 2010, 464:1362-1366.
25. Pecaric-Petkovic T., et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009, 113:1526-1534.
26. Cherry W.B., et al. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 2008, 121:1484-1490.
27. Smithgall M.D., et al. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 2008, 20:1019-1030.
28. Suzukawa M., et al. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 2008, 181:5981-5989.
29. Bourgeois E., et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production. Eur. J. Immunol. 2009, 39:1046-1055.
30. + T cell responses. Science 2012, 335:984-989.
31. + T cells. Eur. J. Immunol. 2011, 41:3351-3360.
32. Baumann C., et al. T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:4056-4061.
33. Schiering C., et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014, 513:564-568.
34. Cayrol C., Girard J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9021-9026.
35. Luthi A.U., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
36. Kopach P., et al. IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism. J. Biol. Chem. 2014, 289:11829-11843.
37. Cohen E.S., et al. Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat. Commun. 2015, 6:8327.
38. Palmer G., Gabay C. Interleukin-33 biology with potential insights into human diseases. Nat. Rev. Rheumatol. 2011, 7:321-329.
39. Lecart S., et al. Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. Eur. J. Immunol. 2002, 32:2979-2987.
40. Bandara G., et al. Activated mast cells synthesize and release soluble ST2 - a decoy receptor for IL-33. Eur. J. Immunol. 2015, 45:3034-3044.
41. Lichtman A.H., et al. Role of interleukin 1 in the activation of T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:9699-9703.
42. Weaver C.T., et al. T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:8181-8185.
43. Ben-Sasson S.Z., et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7119-7124.
44. Ben-Sasson S.Z., et al. IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells. J. Exp. Med. 2013, 210:491-502.
45. Joeckel L.T., et al. Interleukin-1R signaling is essential for induction of proapoptotic CD8 T cells, viral clearance, and pathology during lymphocytic choriomeningitis virus infection in mice. J. Virol. 2012, 86:8713-8719.
46. Molofsky A.B., et al. Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity 2015, 42:1005-1019.
47. Guo L., et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13463-13468.
48. Yagi R., et al. The transcription factor GATA3 is critical for the development of all IL-7Rα-expressing innate lymphoid cells. Immunity 2014, 40:378-388.
49. Zhong C., et al. Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment. Nat. Immunol. 2016, 17:169-178.
50. + Th1/Th2 hybrid cells arise in vivo, can develop directly from naive precursors, and limit immunopathologic inflammation. PLoS Biol. 2013, 11:e1001633.
51. + cell subset with combined Th2 and Th1 cell functions. Immunity 2010, 32:116-128.
52. Ouyang W., et al. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 2000, 12:27-37.
53. Hofer T., et al. GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:9364-9368.
54. Mullen A.C., et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001, 292:1907-1910.
55. Kanhere A., et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat. Commun. 2012, 3:1268.
56. Lighvani A.A., et al. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15137-15142.
57. + T cells. Nat. Immunol. 2002, 3:549-557.
58. Schulz E.G., et al. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-γ and interleukin-12. Immunity 2009, 30:673-683.
59. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.
60. Nurieva R., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
61. Kurata H., et al. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 1999, 11:677688.
62. Onodera A., et al. STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance of GATA3 expression in T helper type 2 cells. J. Exp. Med. 2010, 207:2493-2506.
63. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596.
64. Lee H.J., et al. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 2000, 192:105-115.
65. Takemoto N., et al. Cutting edge: chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster. J. Immunol. 2000, 165:6687-6691.
66. H2 cells. Nat. Immunol. 2011, 12:77-85.
67. Maneechotesuwan K., et al. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J. Immunol. 2007, 178:2491-2498.
68. Wei G., et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 2011, 35:299-311.
69. + regulatory T cells. J. Immunol. 2014, 193:4010-4020.
70. Nakayamada S., et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 2011, 35:919-931.
71. Wei L., et al. Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 2010, 32:840-851.
72. Richter A., et al. Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression. J. Exp. Med. 1999, 190:1439-1450.
73. Bird J.J., et al. Helper T cell differentiation is controlled by the cell cycle. Immunity 1998, 9:229-237.
74. H cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 2002, 3:643-651.
75. + T cells. Immunity 2009, 30:155-167.
76. + cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol. 2011, 187:4598-4610.
77. Brunner S.M., et al. Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transpl. Int. 2011, 24:1027-1039.
78. Nabekura T., et al. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection. J. Immunol. 2015, 194:5948-5952.
79. Wang J.X., et al. IL-33/ST2 axis promotes mast cell survival via BCLXL. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:10281-10286.
80. Garlanda C., et al. The interleukin-1 family: back to the future. Immunity 2013, 39:1003-1018.
81. Sims J.E., Smith D.E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 2010, 10:89-102.
82. + T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 2006, 25:783-793.
83. Maxwell J.R., et al. IL-18 bridges innate and adaptive immunity through IFN-γ and the CD134 pathway. J. Immunol. 2006, 177:234-245.
84. + T cells from activation-induced cell death by IL-18. J. Leukoc. Biol. 2007, 82:142-151.
85. + T cell proliferation. PLoS ONE 2008, 3:e2404.
86. Rahman A.H., et al. MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection. J. Immunol. 2008, 181:3804-3810.
87. Chen L., Flies D.B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013, 13:227-242.
88. Rudd C.E., Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 2003, 3:544-556.
89. Boomer J.S., Green J.M. An enigmatic tail of CD28 signaling. Cold Spring Harb. Perspect. Biol. 2010, 2:a002436.
90. Croft M., et al. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 1994, 152:2675-2685.
91. Flynn K., Mullbacher A. Memory alloreactive cytotoxic T cells do not require costimulation for activation in vitro. Immunol. Cell Biol. 1996, 74:413-420.
92. Bachmann M.F., et al. Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J. Exp. Med. 1999, 189:1521-1530.
93. + T cells require CD28 costimulation. J. Immunol. 2007, 179:6494-6503.
94. + T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J. Immunol. 2008, 180:1148-1157.
95. Ndejembi M.P., et al. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J. Immunol. 2006, 177:7698-7706.
96. Rahman A.H., et al. Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88. Blood 2011, 117:3123-3130.
97. + T cells is required to overcome suppression by regulatory T cells. Immunity 2014, 40:78-90.
98. Kroeger K.M., et al. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38α-dependent pathway. J. Leukoc. Biol. 2009, 86:769-778.
99. Ho L.H., et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-Fce[open]RI signals. J. Leukoc. Biol. 2007, 82:1481-1490.
100. + T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J. Immunol. 2001, 166:3143-3150.
101. Guo L., et al. Innate immunological function of TH2 cells in vivo. Nat. Immunol. 2015, 16:1051-1059.
102. Robinson D., et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 1997, 7:571-581.
103. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 1999, 29:548-555.
104. + T cells contributes to the rapid production of IFN-γ in response to bacterial pathogens. J. Immunol. 2001, 166:1097-1105.
105. + T cells to innate immunity: IFN-γ secretion induced by IL-12 and IL-18. Eur. J. Immunol. 2002, 32:2807-2816.
106. Szabo S.J., et al. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 1997, 185:817-824.
107. Ouyang W., et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998, 9:745-755.
108. Lexberg M.H., et al. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur. J. Immunol. 2010, 40:3017-3027.
109. Xu D., et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 1998, 188:1485-1492.
110. Ivanov I.I., et al. Transcriptional regulation of Th17 cell differentiation. Semin. Immunol. 2007, 19:409-417.
111. + effector T cells. J. Immunol. 2006, 176:7278-7287.
112. Li L., et al. IL-1β-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells. J. Immunol. 2010, 185:4148-4153.
113. Basu R., et al. IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance. Nat. Immunol. 2015, 16:286-295.
114. Oertli M., et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J. Clin. Invest. 2012, 122:1082-1096.
115. + Treg cell function in the intestine. Mucosal Immunol. 2015, 8:1226-1236.
116. Zeiser R., et al. Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease. Biol. Blood Marrow Transplant. 2007, 13:1427-1438.
117. Carroll R.G., et al. Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells. PLoS ONE 2008, 3:e3289.
118. + regulatory T cell activity: it takes (IL-)two to tango. Eur. J. Immunol. 2005, 35:1336-1341.
119. + T cells. Curr. Opin. Immunol. 2009, 21:167-172.
120. Helmstetter C., et al. Individual T helper cells have a quantitative cytokine memory. Immunity 2015, 42:108-122.